Update-Moody's: AbbVie, Amgen and Roche most exposed to biosimilar drugs market

Tue Feb 25, 2014 6:15am EST

Biosimilar drugs market

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.